WallStreetZenWallStreetZen

NASDAQ: QTTB
Q32 Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for QTTB

Based on 3 analysts offering 12 month price targets for Q32 Bio Inc.
Min Forecast
$54.00+11.23%
Avg Forecast
$83.00+70.96%
Max Forecast
$100.00+105.97%

Should I buy or sell QTTB stock?

Based on 3 analysts offering ratings for Q32 Bio Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their QTTB stock forecasts and price targets.

QTTB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-09-11
lockedlocked$00.00+00.00%2024-06-17
lockedlocked$00.00+00.00%2024-05-21

1 of 1

Forecast return on equity

Is QTTB forecast to generate an efficient return?
Company
-239.92%
Industry
-784.34%
Market
48.93%
QTTB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is QTTB forecast to generate an efficient return on assets?
Company
-64.73%
Industry
26.21%
QTTB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

QTTB earnings per share forecast

What is QTTB's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$11.76
Avg 2 year Forecast
-$4.84
Avg 3 year Forecast
-$5.34

QTTB revenue forecast

What is QTTB's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$86.6M
Avg 2 year Forecast
$285.5M
Avg 3 year Forecast
$514.1M

QTTB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
QTTB$48.55$83.00+70.96%Strong Buy
ARCT$21.46$73.00+240.17%Strong Buy
CAPR$17.77$35.60+100.34%Strong Buy
PHAR$8.50$37.00+335.29%Buy
ABVX$9.52$45.75+380.57%Strong Buy
View Top Biotech Stocks

Q32 Bio Stock Forecast FAQ

Is Q32 Bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: QTTB) stock is to Strong Buy QTTB stock.

Out of 3 analysts, 2 (66.67%) are recommending QTTB as a Strong Buy, 1 (33.33%) are recommending QTTB as a Buy, 0 (0%) are recommending QTTB as a Hold, 0 (0%) are recommending QTTB as a Sell, and 0 (0%) are recommending QTTB as a Strong Sell.

If you're new to stock investing, here's how to buy Q32 Bio stock.

What is QTTB's earnings growth forecast for 2024-2026?

(NASDAQ: QTTB) Q32 Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.54%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.87%.

Q32 Bio's earnings in 2024 is -$65,022,000.On average, 3 Wall Street analysts forecast QTTB's earnings for 2024 to be -$141,862,881, with the lowest QTTB earnings forecast at -$150,626,727, and the highest QTTB earnings forecast at -$125,542,372. On average, 3 Wall Street analysts forecast QTTB's earnings for 2025 to be -$58,329,567, with the lowest QTTB earnings forecast at -$74,529,477, and the highest QTTB earnings forecast at -$37,144,141.

In 2026, QTTB is forecast to generate -$64,439,055 in earnings, with the lowest earnings forecast at -$84,418,502 and the highest earnings forecast at -$32,320,226.

What is QTTB's revenue growth forecast for 2028-2030?

(NASDAQ: QTTB) Q32 Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.84%.

Q32 Bio's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast QTTB's revenue for 2028 to be $1,044,075,973, with the lowest QTTB revenue forecast at $495,054,215, and the highest QTTB revenue forecast at $1,593,097,731. On average, 2 Wall Street analysts forecast QTTB's revenue for 2029 to be $3,443,008,604, with the lowest QTTB revenue forecast at $2,400,982,795, and the highest QTTB revenue forecast at $4,485,034,413.

In 2030, QTTB is forecast to generate $6,200,237,477 in revenue, with the lowest revenue forecast at $5,154,955,526 and the highest revenue forecast at $7,245,519,429.

What is QTTB's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: QTTB) forecast ROA is -64.73%, which is lower than the forecast US Biotechnology industry average of 26.21%.

What is QTTB's Price Target?

According to 3 Wall Street analysts that have issued a 1 year QTTB price target, the average QTTB price target is $83.00, with the highest QTTB stock price forecast at $100.00 and the lowest QTTB stock price forecast at $54.00.

On average, Wall Street analysts predict that Q32 Bio's share price could reach $83.00 by Sep 11, 2025. The average Q32 Bio stock price prediction forecasts a potential upside of 70.96% from the current QTTB share price of $48.55.

What is QTTB's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: QTTB) Q32 Bio's current Earnings Per Share (EPS) is -$15.51. On average, analysts forecast that QTTB's EPS will be -$11.76 for 2024, with the lowest EPS forecast at -$12.49, and the highest EPS forecast at -$10.41. On average, analysts forecast that QTTB's EPS will be -$4.84 for 2025, with the lowest EPS forecast at -$6.18, and the highest EPS forecast at -$3.08. In 2026, QTTB's EPS is forecast to hit -$5.34 (min: -$7.00, max: -$2.68).

What is QTTB's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: QTTB) forecast ROE is -239.92%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.